A leader of the Pharmaceutical Biophysics group at the University of Silesia, which dedicates a significant part of its research to nanotechnology. PI of NCN grants (2014/13/D/NZ7/00322, 2020/39/O/NZ5/02342, 2024/55/B/NZ5/03048). Her scientific interests focus on the search for compounds exhibiting anticancer activity. She explores metal-complexing compounds, in particular iron, which participates in many important cellular processes. The last project is focused on the study of ferroptosis – iron-depended type of cell death. Therefore, compounds that have the ability to affect iron homeostasis are an interesting target of drug design. Experience in conducting research on toxicity and molecular response during therapy allows for the study of processes responsible for the toxicity/safety of nanomaterials. The studies include drug carriers, fullerene materials, hydrogel matrices for cosmetics production, biomaterials, veterinary products and innovations in the field of pharmacy.
dr hab. Anna Mrozek-Wilczkiewicz
University of Silesia in Katowice, Silesian University of Technology